Association between busulfan exposure and outcome in children receiving intravenous busulfan before haematopoietic stem cell transplantation

被引：0
|
作者：
Ansari, M.
Theoret, Y.
Rezgui, M.
Mezziani, S.
Desjean, C.
Vachon, M.
Labuda, M.
Champagne, M.
Duval, M.
Peters, C.
Krajinovic, M.
Bittencourt, H.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S40 / S41
页数：2
相关论文
共 50 条
  • [1] Association between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan before Hematologic Stem Cell Transplantation
    Bartelink, Imke H.
    Bredius, Robert G. M.
    Belitser, Svetlana V.
    Suttorp, Marit M.
    Bierings, Marc
    Knibbe, Catherijne A. J.
    Egeler, Maarten
    Lankester, Arjan C.
    Egberts, Atoine C. G.
    Zwaveling, Juliette
    Boelens, Jaap Jan
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 231 - 241
  • [2] Association Between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan Before Hematopoietic Stem Cell Transplantation
    Ansari, Marc
    Theoret, Yves
    Rezgui, Mohamed Aziz
    Peters, Christina
    Mezziani, Samira
    Desjean, Catherine
    Vachon, Marie-France
    Champagne, Martin A.
    Duval, Michel
    Krajinovic, Maja
    Bittencourt, Henrique
    [J]. THERAPEUTIC DRUG MONITORING, 2014, 36 (01) : 93 - 99
  • [3] Intravenous busulfan in paediatric haematopoietic stem cell transplantation
    Kuskonmaz, B.
    Unal, S.
    Akan, A.
    Cetin, N.
    Akyol, F.
    Cetin, M.
    Tezcan, I.
    Uckan, D.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 39 : S304 - S304
  • [4] Intravenous busulfan before autologous stem cell transplantation in children with cancer
    Le Guyader, N.
    Landre, T.
    Haouy, S.
    Landman-Parker, J.
    Fasola, S.
    Auvrignon, A.
    Leverger, G.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S302 - S302
  • [5] Efficacy and toxicity of intravenous busulfan before hematopoietic stem cell transplantation in children
    Styczynski, Jan
    Debski, Robert
    Krenska, Anna
    Wysocki, Mariusz
    [J]. BONE MARROW TRANSPLANTATION, 2008, 42 : S126 - S126
  • [6] Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation
    Curtis, P. Huezo-Diaz
    Uppugunduri, C. R. S.
    Muthukumaran, J.
    Rezgui, M. A.
    Peters, C.
    Bader, P.
    Duval, M.
    Bittencourt, H.
    Krajinovic, Maja
    Ansari, Marc
    [J]. PHARMACOGENOMICS JOURNAL, 2018, 18 (01): : 64 - 69
  • [7] Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation
    P Huezo-Diaz Curtis
    C R S Uppugunduri
    J Muthukumaran
    M A Rezgui
    C Peters
    P Bader
    M Duval
    H Bittencourt
    Maja Krajinovic
    Marc Ansari
    [J]. The Pharmacogenomics Journal, 2018, 18 : 64 - 69
  • [8] Higher incidence of hypertension with intravenous busulfan compared to oral busulfan in thalassaemic children who underwent haematopoietic stem cell transplantation
    Tayfun, F.
    Baytan, B.
    Ozdemir, G. N.
    Akcan, M.
    Uygun, V.
    Karasu, G.
    Yesilipek, A.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 : S186 - S186
  • [9] Quantification of busulfan in saliva and plasma in haematopoietic stem cell transplantation in children
    Rauh, M
    Stachel, D
    Kuhlen, M
    Gröschl, M
    Holter, W
    Rascher, W
    [J]. CLINICAL PHARMACOKINETICS, 2006, 45 (03) : 305 - 316
  • [10] Pharmacokinetics of intravenous busulfan in children prior to stem cell transplantation
    Cremers, S
    Schoemaker, R
    Bredius, R
    den Hartigh, J
    Ball, L
    Twiss, I
    Vermeij, P
    Vossen, J
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (04) : 386 - 389
12345